Unknown

Dataset Information

Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations.


ABSTRACT: The Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) was a 12-month, Phase III, open-label, randomised study comparing the effectiveness and safety of initiating once-daily fluticasone furoate 100 µg/vilanterol 25 µg (FF/VI) with continuing usual care (UC). Follow-up interviews were conducted among a subset of 400 patients who completed SLS COPD to further understand patients' experiences with treatment outcomes and the impact of COPD, and potential risk factors associated with higher rates of exacerbations during SLS COPD. Another objective was to explore how such patient-centred outcomes differed by randomised treatment. Patients' perceived control over COPD and effects on quality of life (QoL) were similar between treatment groups at the time of the follow-up inter

SUBMITTER: Whalley D 

PROVIDER: S-EPMC6509249 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature